Manfred P. Lutz

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Alberto Sobrero, Joan Maurel, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2008 · 952 citations · Full text

Medicine, Oncology, Pharmacology +14

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

Christoph Schuhmacher, Stephan Gretschel, Florian Lordick et al. · Journal of Clinical Oncology · 2010 · 714 citations

Medicine, Oncology, Surgery +17

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

Theo J. M. Ruers, Cornelis J.A. Punt, Frits van Coevorden et al. · Annals of Oncology · 2012 · 437 citations · Full text

Medicine, Oncology, Surgery +17

Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Claus Henning Köhne, Eric Van Cutsem, J. Wils et al. · Journal of Clinical Oncology · 2005 · 329 citations

Medicine, Oncology, Pharmacotherapy +16

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Jean–Luc Van Laethem, Pascal Hammel, F. Mornex et al. · Journal of Clinical Oncology · 2010 · 295 citations · Full text

Medicine, Oncology, Surgery +17